04.11.2015
MediClin AG DE0006595101
DGAP-News: MediClin AG: In the first nine months of the 2015 financial year, Group sales increased by 2.9 % up to EUR 414.4 mill. and the Group operating result improved from EUR 12.2 mill. to EUR 17.4 mill.
DGAP-News: MediClin AG / Key word(s): 9-month figures
MediClin AG: In the first nine months of the 2015 financial year,
Group sales increased by 2.9 % up to EUR 414.4 mill. and the Group
operating result improved from EUR 12.2 mill. to EUR 17.4 mill.
04.11.2015 / 15:21
---------------------------------------------------------------------
MediClin: In the first nine months of the 2015 financial year, Group sales
increased by 2.9 % up to EUR 414.4 mill. and the Group operating result
improved from EUR 12.2 mill. to EUR 17.4 mill.
Offenburg, November 4, 2015 - In the first nine months of the 2015
financial year, MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales
of EUR 414.4 mill. (9M 2014: EUR 402.8 mill.) thus being EUR 11.6 mill. or
2.9 % above the comparable period of the previous year. Group occupancy
rate amounted to 87.7 % (9M 2014: 87.6 %).
Raw materials and consumables used declined by EUR 3.1 mill. against
previous year's value. Staff costs increased by EUR 7.7 mill. primarily due
to the higher headcount. Depreciation and amortisation were up EUR 0.5
mill. and other operating expenses were up EUR 1.6 mill. on the respective
previous years values.
The Group operating result improved by EUR 5.2 mill. up from EUR 12.2 mill.
to EUR 17.4 mill. and the consolidated result attributable to shareholders
of MediClin AG increased by EUR 4.5 mill. from EUR 8.0 mill. to EUR 12.5
mill. compared to the previous year's period.
Business development in the segments
In the Post-acute segment, the good sales development of the previous
quarters also continued in the third quarter of 2015. Sales in the acute
segment were only EUR 0.5 mill. below the previous year's comparable
quarter in the third quarter of 2015 (Q1 2015: EUR -1.3 mill.; Q2 2015: EUR
-0.8 mill.), indicating an improvement in the sales performance. This is
also supported by the number of cases, which increased again compared to
the second quarter of 2015, nearly reaching the level of the third quarter
of 2014.
A comparison with the first nine months of the previous year reveals that
sales in the post-acute segment rose by EUR 13.3 mill. (+5.7 %) based on a
similar occupancy level as in the previous year and a slightly longer
length of stay. Due to a lower number of cases and case mix points, sales
in the acute segment were EUR 2.6 mill. (-1.7 %) lower than the previous
year's value. A slight increase in occupancy led to a EUR 0.6 mill.
increase(+6.6 %) in sales in the nursing care business area.
Also in the nine-month view higher sales in the post-acute segment let to
an increase of the segment result from EUR 10.8 mill. to EUR 15.8 mill. In
the acute segment the decline in sales could be offset by lower expenses,
so that a segment result of EUR 7.2 mill. could be achieved, being EUR 0.5
mill. above previous year's value.
In the first nine months of the 2015 financial year, EUR 20.0 mill. (gross)
was invested, thereof financed with subsidies EUR 1.7 mill. (9M 2014: EUR
14.2 mill. thereof with subsidies EUR 3.0 mill.).
Cash and cash equivalents as of 30 September 2015 amounted to EUR 30.2
mill. (31.12.2014: EUR 26.3 mill.). The equity ratio was 49.1% (31.12.2014:
48.2 %).
MediClin employed on average 6,500 employees (9M 2014: 6,405 employees),
calculated on the basis of full-time staff, in the first nine months of the
2015 financial year.
Outlook
The business performance in the first nine months of the 2015 financial
year indicates that the sales target of 3.0 % growth announced for the
Group will be presumably reached. As for earnings, the Management Board
assumes that Group EBIT will range between EUR 19 mill. and EUR 21 mill.,
provided the post-acute segment continues to perform well.
The post-acute segment is expected to reach its sales and earnings targets.
In the acute segment, the Management Board expects a sales decline, but
assumes that the earnings target for the segment will be achieved thanks to
process and cost optimisation measures.
The interim report as of September 30, 2015 will be available in German and
English from November 6, 2015 under www.mediclin.de.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics, 7 nursing care facilities and 8 medical care centres in 11 federal
states MediClin has a total capacity of approximately 8,000 beds.
MediClins' facilities include acute care clinics, i.e., general hospitals,
special treatment facilities, specialised hospitals and clinics for
post-acute treatment and medical rehabilitation. MediClin has approximately
9,000 employees.
MediClin ─ a company of the Asklepios Group
---------------------------------------------------------------------
04.11.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
Stuttgart
End of News DGAP News Service
---------------------------------------------------------------------
408789 04.11.2015
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
MediClin AG ISIN: DE0006595101 können Sie bei EQS abrufen
Pflegeeinrichtungen , 659510 , MED , XETR:MED